Viridien


17/03/26 -"Group revenues reach $1,131M in 2026 (vs $1,159M) and $1,169M in 2027, with a mix shift favouring higher-margin Geoscience ($462M in 2026, growing to $489M in 2027 and $519M in 2028) at the expense ..."

Pages
88
Language
English
Published on
17/03/26
You may also be interested by these reports :
17/03/26
Group revenues reach $1,131M in 2026 (vs $1,159M) and $1,169M in 2027, with a mix shift favouring higher-margin Geoscience ($462M in 2026, growing to ...

12/03/26
EPS upgrades are underpinned by a broad-based P&L revision. Group EBIT reaches EUR 2,995M in 2026 (vs EUR 2,131M), EUR 2,876M in 2027 (vs EUR 2,263M) ...

12/03/26
Under base case of contained escalation, Brent trades around $100-105/bbl after briefly touching $120 at the Asian open (monday). The move reflects ...

10/03/26
Our EPS estimates now incorporate FY2025 actual results and an updated share count. Reported net profit came in at -EUR 20.5M, weighed down by EUR ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO